Disc Medicine Inc.

NASDAQ: IRON · Real-Time Price · USD
60.23
-0.49 (-0.81%)
At close: Aug 15, 2025, 12:10 PM

Disc Medicine Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
156K 100K 300K 192K
Gross Profit
-156K -100K -300K -192K
Operating Income
-129.72M -91.13M -47.48M -30.93M
Interest Income
21.29M 14.8M 709K 14K
Pretax Income
-109M -76.33M -46.83M -35.97M
Net Income
-109.36M -76.43M -46.83M -35.97M
Selling & General & Admin
33.05M 21.86M 14.04M 5.76M
Research & Development
96.52M 69.16M 33.44M 25.17M
Other Expenses
n/a 100K n/a n/a
Operating Expenses
129.56M 91.13M 47.48M 30.93M
Interest Expense
572K n/a n/a 2.16M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-129.72M 91.13M 47.48M 30.93M
Income Tax Expense
355K 99K -737K n/a
Shares Outstanding (Basic)
27.61M 22.32M 11.64M 4.32M
Shares Outstanding (Diluted)
27.61M 22.32M 11.64M 4.32M
EPS (Basic)
-3.96 -3.42 -3.96 -9.49
EPS (Diluted)
-3.96 -3.42 -3.96 -9.49
EBITDA
-108.27M -91.03M -47.39M -30.9M
EBIT
-108.43M -91.13M -47.48M -30.93M
Depreciation & Amortization
156K 100K 89K 32K